Published in EMBO J on March 01, 1987
Rescue of measles viruses from cloned DNA. EMBO J (1995) 7.87
Measles virus spread and pathogenesis in genetically modified mice. J Virol (1998) 2.84
A matrix-less measles virus is infectious and elicits extensive cell fusion: consequences for propagation in the brain. EMBO J (1998) 2.48
Retracted Infectious measles virus from cloned cDNA. EMBO J (1990) 2.36
Targeted cell entry of lentiviral vectors. Mol Ther (2008) 2.34
HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells. J Virol (1989) 2.11
Multiple viral mutations rather than host factors cause defective measles virus gene expression in a subacute sclerosing panencephalitis cell line. J Virol (1988) 1.84
Tropism illuminated: lymphocyte-based pathways blazed by lethal morbillivirus through the host immune system. Proc Natl Acad Sci U S A (2004) 1.84
Retracted Functional and nonfunctional measles virus matrix genes from lethal human brain infections. J Virol (1991) 1.82
Expression of measles virus V protein is associated with pathogenicity and control of viral RNA synthesis. J Virol (1998) 1.63
Long untranslated regions of the measles virus M and F genes control virus replication and cytopathogenicity. J Virol (2005) 1.61
Dynamics of viral RNA synthesis during measles virus infection. J Virol (2005) 1.44
Nonstructural C protein is required for efficient measles virus replication in human peripheral blood cells. J Virol (1999) 1.37
The length and sequence composition of vesicular stomatitis virus intergenic regions affect mRNA levels and the site of transcript initiation. J Virol (1998) 1.37
Antibody-induced restriction of viral gene expression in measles encephalitis in rats. J Virol (1990) 1.36
A vectored measles virus induces hepatitis B surface antigen antibodies while protecting macaques against measles virus challenge. J Virol (2007) 1.34
Cell type-specific MxA-mediated inhibition of measles virus transcription in human brain cells. J Virol (1994) 1.34
A recombinant measles virus expressing hepatitis B virus surface antigen induces humoral immune responses in genetically modified mice. J Virol (1999) 1.33
Interplay between innate immunity and negative-strand RNA viruses: towards a rational model. Microbiol Mol Biol Rev (2011) 1.22
Measles virus phosphoprotein gene products: conformational flexibility of the P/V protein amino-terminal domain and C protein infectivity factor function. J Virol (2004) 1.21
Detection of measles virus RNA in urine specimens from vaccine recipients. J Clin Microbiol (1995) 1.19
A procedure for selective full length cDNA cloning of specific RNA species. Nucleic Acids Res (1987) 1.15
Measles virus, immune control, and persistence. FEMS Microbiol Rev (2012) 1.12
The matrix proteins of neurovirulent subacute sclerosing panencephalitis virus and its acute measles virus progenitor are functionally different. Proc Natl Acad Sci U S A (1992) 1.07
Subacute sclerosing panencephalitis virus dominantly interferes with replication of wild-type measles virus in a mixed infection: implication for viral persistence. J Virol (1992) 1.03
Rinderpest viruses lacking the C and V proteins show specific defects in growth and transcription of viral RNAs. J Virol (2000) 1.02
Spontaneous and differentiation-dependent regulation of measles virus gene expression in human glial cells. J Virol (1993) 1.02
Inhibition of ubiquitination and stabilization of human ubiquitin E3 ligase PIRH2 by measles virus phosphoprotein. J Virol (2005) 0.99
Recombinant respiratory syncytial virus with the G and F genes shifted to the promoter-proximal positions. J Virol (2002) 0.98
Antibody-dependent transcriptional regulation of measles virus in persistently infected neural cells. J Virol (1992) 0.97
In vivo ligands of MDA5 and RIG-I in measles virus-infected cells. PLoS Pathog (2014) 0.97
Amino-terminal precursor sequence modulates canine distemper virus fusion protein function. J Virol (2002) 0.97
Making it to the synapse: measles virus spread in and among neurons. Curr Top Microbiol Immunol (2009) 0.96
Measles viruses possessing the polymerase protein genes of the Edmonston vaccine strain exhibit attenuated gene expression and growth in cultured cells and SLAM knock-in mice. J Virol (2008) 0.96
Cloning and sequencing of the nucleoprotein gene of measles virus (Hallé strain). Nucleic Acids Res (1988) 0.94
Suppression of the Sendai virus M protein through a novel short interfering RNA approach inhibits viral particle production but does not affect viral RNA synthesis. J Virol (2006) 0.94
A novel armed oncolytic measles vaccine virus for the treatment of cholangiocarcinoma. Hum Gene Ther (2013) 0.93
Polymerase read-through at the first transcription termination site contributes to regulation of borna disease virus gene expression. J Virol (2008) 0.92
Measles virus C protein impairs production of defective copyback double-stranded viral RNA and activation of protein kinase R. J Virol (2013) 0.89
A recombinant, infectious human parainfluenza virus type 3 expressing the enhanced green fluorescent protein for use in high-throughput antiviral assays. Antiviral Res (2009) 0.88
Mutant fusion proteins with enhanced fusion activity promote measles virus spread in human neuronal cells and brains of suckling hamsters. J Virol (2012) 0.84
Reverse genetics of Mononegavirales: How they work, new vaccines, and new cancer therapeutics. Virology (2015) 0.83
Analysis of the highly diverse gene borders in Ebola virus reveals a distinct mechanism of transcriptional regulation. J Virol (2014) 0.83
Rescue of a chimeric rinderpest virus with the nucleocapsid protein derived from peste-des-petits-ruminants virus: use as a marker vaccine. J Gen Virol (2007) 0.83
The F gene of the Osaka-2 strain of measles virus derived from a case of subacute sclerosing panencephalitis is a major determinant of neurovirulence. J Virol (2010) 0.83
Vaccine platform recombinant measles virus. Virus Genes (2017) 0.81
Live-attenuated measles virus vaccine targets dendritic cells and macrophages in muscle of nonhuman primates. J Virol (2014) 0.81
Comparative analysis of viral RNA signatures on different RIG-I-like receptors. Elife (2016) 0.80
Generation of measles virus defective interfering particles and their presence in a preparation of attenuated live-virus vaccine. J Virol (1988) 0.79
Mutations affecting transcriptional termination in the p gene end of subacute sclerosing panencephalitis viruses. J Virol (2002) 0.79
Hyperediting of human T-cell leukemia virus type 2 and simian T-cell leukemia virus type 3 by the dsRNA adenosine deaminase ADAR-1. J Gen Virol (2012) 0.77
Loss of the endothelin signal pathway in C6 rat glioma cells persistently infected with measles virus. Proc Natl Acad Sci U S A (1991) 0.77
Tyrosine phosphorylation of measles virus nucleocapsid protein in persistently infected neuroblastoma cells. J Virol (1995) 0.77
Contribution of matrix, fusion, hemagglutinin, and large protein genes of the CAM-70 measles virus vaccine strain to efficient growth in chicken embryonic fibroblasts. J Virol (2009) 0.77
Establishment of an in vitro transcription system for Peste des petits ruminant virus. Virol J (2012) 0.76
Clearance of measles virus from persistently infected cells by short hairpin RNA. J Virol (2009) 0.76
Progress towards Rapid Detection of Measles Vaccine Strains: a Tool To Inform Public Health Interventions. J Clin Microbiol (2016) 0.75
Modulation of Re-initiation of Measles Virus Transcription at Intergenic Regions by PXD to NTAIL Binding Strength. PLoS Pathog (2016) 0.75
Organization, Function, and Therapeutic Targeting of the Morbillivirus RNA-Dependent RNA Polymerase Complex. Viruses (2016) 0.75
Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol (1980) 287.68
Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene (1985) 213.67
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry (1979) 180.95
Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res (1984) 86.56
Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing. J Mol Biol (1980) 61.16
A simple and very efficient method for generating cDNA libraries. Gene (1983) 55.36
Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur J Biochem (1980) 26.55
pEMBL: a new family of single stranded plasmids. Nucleic Acids Res (1983) 19.19
Rapid evolution of RNA genomes. Science (1982) 14.76
Localized attenuation and discontinuous synthesis during vesicular stomatitis virus transcription. Cell (1981) 5.38
Complete intergenic and flanking gene sequences from the genome of vesicular stomatitis virus. Cell (1980) 5.32
Hepatitis B virus transcription in the infected liver. EMBO J (1984) 3.44
The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance--a review. Gene (1985) 3.42
Measles virus P gene codes for two proteins. J Virol (1985) 3.31
Determination of molar ratios of vesicular stomatitis virus induced RNA species in BHK21 cells. Biochemistry (1976) 2.69
Complete sequences of the intergenic and mRNA start signals in the Sendai virus genome: homologies with the genome of vesicular stomatitis virus. Nucleic Acids Res (1984) 2.45
A novel transcription property of SP6 and T7 RNA polymerases: dependence on template structure. Nucleic Acids Res (1985) 2.25
Polycistronic vesicular stomatitis virus RNA transcripts. Proc Natl Acad Sci U S A (1980) 2.16
Multiple sclerosis and human T-cell lymphotropic retroviruses. Nature (1985) 1.96
Intervening polyadenylate sequences in RNA transcripts of vesicular stomatitis virus. Cell (1978) 1.92
Expression of defective measles virus genes in brain tissues of patients with subacute sclerosing panencephalitis. J Virol (1986) 1.84
Human parainfluenza virus type 3: messenger RNAs, polypeptide coding assignments, intergenic sequences, and genetic map. J Virol (1986) 1.78
The nucleotide sequence of the mRNA encoding the fusion protein of measles virus (Edmonston strain): a comparison of fusion proteins from several different paramyxoviruses. Virology (1986) 1.76
Matrix genes of measles virus and canine distemper virus: cloning, nucleotide sequences, and deduced amino acid sequences. J Virol (1986) 1.74
The predicted primary structure of the measles virus hemagglutinin. Virology (1986) 1.70
Sequence homology within the morbilliviruses. J Virol (1985) 1.56
RNA virus genomes hybridize to cellular rRNAs and to each other. J Virol (1986) 1.51
Accumulated measles virus mutations in a case of subacute sclerosing panencephalitis: interrupted matrix protein reading frame and transcription alteration. Virology (1986) 1.49
Evidence for lack of synthesis of the M polypeptide of measles virus in brain cells in subacute sclerosing panencephalitis. Virology (1979) 1.48
Measles virus nucleotide sequences: detection by hybridization in situ. Science (1981) 1.45
Differences between the intracellular polypeptides of measles and subacute sclerosing panencephalitis virus. Nature (1978) 1.41
Detection of in vivo synthesis of polycistronic mRNAs of vesicular stomatitis virus. Virology (1984) 1.39
Rapid degradation restricts measles virus matrix protein expression in a subacute sclerosing panencephalitis cell line. Proc Natl Acad Sci U S A (1986) 1.38
Cloning of DNA corresponding to four different measles virus genomic regions. Virology (1984) 1.38
Measles virus: conditions for the propagation and purification of infectious virus in high yield. J Virol Methods (1984) 1.35
Poliovirus genome RNA hybridizes specifically to higher eukaryotic rRNAs. Nucleic Acids Res (1985) 1.33
Induction of subacute murine measles encephalitis by monoclonal antibody to virus haemagglutinin. Nature (1981) 1.30
Measles and SSPE viruses: similarities and differences. Prog Med Virol (1982) 1.30
Structural and functional characterization of Newcastle disease virus polycistronic RNA species. J Virol (1984) 1.28
Restricted expression of measles virus proteins in brains from cases of subacute sclerosing panencephalitis. J Gen Virol (1986) 1.27
Defective translation of measles virus matrix protein in a subacute sclerosing panencephalitis cell line. Nature (1983) 1.25
Mechanisms in multiple sclerosis. Nature (1985) 1.22
Measles virus gene expression in subacute sclerosing panencephalitis. Virus Res (1984) 1.22
Polytranscripts of Sendai virus do not contain intervening polyadenylate sequences. Virology (1985) 1.19
Absence of M protein in a cell-associated subacute sclerosing panencephalitis virus. Nature (1980) 1.19
Isolation and characterization of measles virus intracellular nucleocapsid RNA. J Virol (1984) 1.18
Rates of initiation of protein synthesis by two purified species of vesicular stomatitis virus messenger RNA. J Biol Chem (1977) 1.18
Measles virus persistency and disease. Prog Med Virol (1984) 1.16
Measles virus matrix protein detected by immune fluorescence with monoclonal antibodies in the brain of patients with subacute sclerosing panencephalitis. J Virol (1985) 1.15
Natural history of restricted synthesis and expression of measles virus genes in subacute sclerosing panencephalitis. Proc Natl Acad Sci U S A (1985) 1.14
Measles control: so near and yet so far. Prog Med Virol (1985) 1.14
Membrane and cytoplasmic changes in virus-infected cells induced by interactions of antiviral antibody with surface viral antigen. Prog Med Virol (1980) 1.02
Effect of measles virus antibodies on a measles SSPE virus persistently infected C6 rat glioma cell line. J Gen Virol (1985) 0.98
Cells infected with a cell-associated subacute sclerosing panencephalitis virus do not express M protein. Virology (1981) 0.98
Antigenic modulation induced by monoclonal antibodies: antibodies to measles virus hemagglutinin alters expression of other viral polypeptides in infected cells. J Immunol (1984) 0.97
Characterization of clones for the sixth (L) gene and a transcriptional map for morbilliviruses. J Gen Virol (1986) 0.97
M protein instability and lack of H protein processing associated with nonproductive persistent infection of HeLa cells by measles virus. Virology (1985) 0.95
Transcriptional map of the measles virus genome. J Gen Virol (1986) 0.95
Lack of evidence for involvement of known human retroviruses in multiple sclerosis. Nature (1986) 0.95
Decay of vesicular stomatitis virus mRNAs in vivo. Virology (1979) 0.94
Characterization of messenger RNAs of measles virus. J Gen Virol (1986) 0.92
Biological and biochemical characterization of a latent subacute sclerosing panencephalitis (SSPE) virus infection in tissue culture. J Med Virol (1977) 0.90
Analysis of human T-lymphotrophic virus sequences in multiple sclerosis tissue. Nature (1986) 0.88
Sequence of the Sendai virus L gene: open reading frames upstream of the main coding region suggest that the gene may be polycistronic. Virology (1986) 0.86
Measles virus nucleic acid sequences in human brain. Virus Res (1986) 0.81
Rescue of measles viruses from cloned DNA. EMBO J (1995) 7.87
Signals regulating hepatitis B surface antigen transcription. Nature (1983) 5.02
Biased hypermutation and other genetic changes in defective measles viruses in human brain infections. Cell (1988) 4.90
The nucleotide sequence complexity of avian tumor virus RNA. Proc Natl Acad Sci U S A (1974) 4.86
A physical map of the Rous sarcoma virus genome. J Mol Biol (1976) 4.56
Replication strategy of human hepatitis B virus. J Virol (1987) 4.42
Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc Natl Acad Sci U S A (1991) 4.07
Mapping of biological functions on RNA of avian tumor viruses: location of regions required for transformation and determination of host range. Proc Natl Acad Sci U S A (1975) 4.01
Hepatitis B virus transcription in the infected liver. EMBO J (1984) 3.44
Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence. J Virol (1998) 3.27
Measles virus editing provides an additional cysteine-rich protein. Cell (1989) 3.22
The biology and pathogenesis of coronaviruses. Curr Top Microbiol Immunol (1982) 3.12
Localization of Q-beta maturation cistron ribosome binding site. Nat New Biol (1971) 2.91
Ion selectivity of gram-negative bacterial porins. J Bacteriol (1985) 2.87
Measles virus spread and pathogenesis in genetically modified mice. J Virol (1998) 2.84
Cloned HBV DNA causes hepatitis in chimpanzees. Nature (1982) 2.80
Genomic RNA of the murine coronavirus JHM. J Gen Virol (1978) 2.78
Ilizarov treatment of tibial nonunions with bone loss. Clin Orthop Relat Res (1989) 2.71
Structure of the FMDV translation initiation site and of the structural proteins. Nucleic Acids Res (1983) 2.58
Avian myeloblastosis virus RNA is terminally redundant: implications for the mechanism of retrovirus replication. Cell (1977) 2.55
Biased hypermutation of viral RNA genomes could be due to unwinding/modification of double-stranded RNA. Cell (1989) 2.54
Structure and function of phage RNA. Annu Rev Biochem (1973) 2.50
A matrix-less measles virus is infectious and elicits extensive cell fusion: consequences for propagation in the brain. EMBO J (1998) 2.48
Replication of viral ribonucleic acid. IX. Properties of double-stranded RNA from Escherichia coli infected with bacteriophage MS2. J Mol Biol (1966) 2.45
The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide. Ann Rheum Dis (2010) 2.38
Coronavirus JHM: cell-free synthesis of structural protein p60. J Virol (1980) 2.37
Retracted Infectious measles virus from cloned cDNA. EMBO J (1990) 2.36
Observation of measles virus cell-to-cell spread in astrocytoma cells by using a green fluorescent protein-expressing recombinant virus. J Virol (1999) 2.34
The transcriptional transactivator of human foamy virus maps to the bel 1 genomic region. Proc Natl Acad Sci U S A (1991) 2.23
Infectious hepatitis B virus from cloned DNA of known nucleotide sequence. Proc Natl Acad Sci U S A (1985) 2.20
Rescue of synthetic measles virus minireplicons: measles genomic termini direct efficient expression and propagation of a reporter gene. Virology (1995) 2.11
Coronavirus JHM: intracellular protein synthesis. J Gen Virol (1981) 2.05
Mechanism of sugar transport through the sugar-specific LamB channel of Escherichia coli outer membrane. J Membr Biol (1987) 2.05
Increasing the rate of chromatin remodeling and gene activation--a novel role for the histone acetyltransferase Gcn5. EMBO J (2001) 2.04
Pore formation by LamB of Escherichia coli in lipid bilayer membranes. J Bacteriol (1986) 2.02
Cadence-power-relationship during decisive mountain ascents at the Tour de France. Int J Sports Med (2007) 2.02
Recombinant measles viruses defective for RNA editing and V protein synthesis are viable in cultured cells. Virology (1997) 2.01
A nucleosome precludes binding of the transcription factor Pho4 in vivo to a critical target site in the PHO5 promoter. EMBO J (1994) 2.00
Sequence divergence of measles virus haemagglutinin during natural evolution and adaptation to cell culture. J Gen Virol (1997) 2.00
Preferential initiation at the second AUG of the measles virus F mRNA: a role for the long untranslated region. Virology (1995) 1.96
Chromatin remodelling at the PHO8 promoter requires SWI-SNF and SAGA at a step subsequent to activator binding. EMBO J (1999) 1.96
The nonstructural C protein is not essential for multiplication of Edmonston B strain measles virus in cultured cells. Virology (1996) 1.95
CD150 (SLAM) is a receptor for measles virus but is not involved in viral contact-mediated proliferation inhibition. J Virol (2001) 1.94
Receptor usage and differential downregulation of CD46 by measles virus wild-type and vaccine strains. Proc Natl Acad Sci U S A (1995) 1.89
Interaction of measles virus glycoproteins with the surface of uninfected peripheral blood lymphocytes induces immunosuppression in vitro. Proc Natl Acad Sci U S A (1996) 1.89
The hemagglutinin of canine distemper virus determines tropism and cytopathogenicity. J Virol (2001) 1.88
Measles virus envelope glycoproteins hetero-oligomerize in the endoplasmic reticulum. J Biol Chem (2001) 1.87
Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression. Proc Natl Acad Sci U S A (1997) 1.85
Sequence of the first 175 nucleotides from the 5' terminus of Qbeta RNA synthesized in vitro. Nature (1969) 1.84
Expression of defective measles virus genes in brain tissues of patients with subacute sclerosing panencephalitis. J Virol (1986) 1.84
Multiple viral mutations rather than host factors cause defective measles virus gene expression in a subacute sclerosing panencephalitis cell line. J Virol (1988) 1.84
Systemic therapy of myeloma xenografts by an attenuated measles virus. Blood (2001) 1.84
A novel expression selection approach allows precise mapping of the hepatitis B virus enhancer. Nucleic Acids Res (1985) 1.82
Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice. Blood (2001) 1.82
Retracted Functional and nonfunctional measles virus matrix genes from lethal human brain infections. J Virol (1991) 1.82
Mutated and hypermutated genes of persistent measles viruses which caused lethal human brain diseases. Virology (1989) 1.82
Studies on the structure and synthesis of Rous sarcoma virus RNA. Cold Spring Harb Symp Quant Biol (1975) 1.80
Expression of hepatitis B antigens with a simian virus 40 vector. J Virol (1984) 1.80
Analysis of the comparative workflow and performance characteristics of the VITEK 2 and Phoenix systems. J Clin Microbiol (2005) 1.79
Initiation sites of Rous sarcoma virus RNA-directed DNA synthesis in vitro. Nature (1976) 1.77
Measles virus phosphoprotein retains the nucleocapsid protein in the cytoplasm. Virology (1991) 1.77
Chimeric measles viruses with a foreign envelope. J Virol (1998) 1.75
Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies. J Virol (2000) 1.74
Blood volume and hemoglobin mass in elite athletes of different disciplines. Int J Sports Med (2001) 1.73
Pore-forming activity of the Tsx protein from the outer membrane of Escherichia coli. Demonstration of a nucleoside-specific binding site. J Biol Chem (1988) 1.72
Absence of Gcn5 HAT activity defines a novel state in the opening of chromatin at the PHO5 promoter in yeast. Mol Cell (1998) 1.71
Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations. Lupus (1999) 1.70
Pore formation by the Escherichia coli hemolysin: evidence for an association-dissociation equilibrium of the pore-forming aggregates. Infect Immun (1989) 1.69
Intravenous cyclophosphamide therapy for systemic sclerosis. A single-center experience and review of the literature with pooled analysis of lung function test results. Clin Exp Rheumatol (2004) 1.68
Hyperinducibility of Ia antigen on astrocytes correlates with strain-specific susceptibility to experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (1987) 1.68
Clinical and morphological features of kidney involvement in primary Sjögren's syndrome. Nephrol Dial Transplant (2001) 1.67
Infectious DNA of the human spumaretrovirus. Nucleic Acids Res (1990) 1.67
Expression of measles virus V protein is associated with pathogenicity and control of viral RNA synthesis. J Virol (1998) 1.63
RNA polymerase II holoenzyme recruitment is sufficient to remodel chromatin at the yeast PHO5 promoter. Cell (1997) 1.63
Recombinant measles viruses with mutations in the C, V, or F gene have altered growth phenotypes in vivo. J Virol (1998) 1.62
Comparison of subacute sclerosing panencephalitis and measles viruses: an electron microscope study. J Virol (1971) 1.61
Temporal and geographical distribution of measles virus genotypes. J Gen Virol (1995) 1.61